The Innovator International Developed 10 Buffer ETF - Quarterly (IBUF) stands out as a defined-outcome ETF that delivers exposure to international developed-market equities along with a measure of downside protection. IBUF is part of Innovator's Buffer ETF lineup, which focuses on limiting losses over a defined period in return for capping potential gains. This structure tends to draw interest from investors looking for participation in foreign developed markets while favoring a more measured return profile.
Issued by Innovator Capital Management, IBUF trades on NYSE Arca. The fund launched on July 1, 2024, and carries an expense ratio of 0.85%. Unlike traditional index ETFs, it is actively managed. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The strategy revolves around a quarterly outcome period of roughly three months. In each period, IBUF aims to follow the price return of its reference asset—the iShares MSCI EAFE ETF (EFA)—up to a set upside cap while buffering the first 10% of losses. The MSCI EAFE Index covers large- and mid-cap stocks in developed markets across Europe, Australasia, and the Far East, excluding the United States and Canada. Both the cap and buffer reset at the start of each new period, and the ETF can be held indefinitely.
Implementation relies primarily on FLEX Options tied to the underlying EFA. The fund normally invests at least 80% of its net assets in these options and is classified as non-diversified.
As a defined-outcome fund built with options, IBUF's holdings differ from those of a standard stock ETF. It typically holds a small number of call and put option contracts linked to EFA, plus a modest cash position. Its effective sector exposure therefore aligns with that of the iShares MSCI EAFE ETF. The MSCI EAFE Index has historically shown notable weightings in financials, industrials, healthcare, technology, and consumer sectors.
Investors turn to IBUF for international diversification paired with a defined risk-and-return profile. The fund provides developed-market exposure outside the U.S. while seeking to cushion the first portion of any quarterly decline. This can appeal to more cautious investors, retirees, and those with specific risk tolerances, given the trade-off of capped upside.
The quarterly reset is another notable feature. Rather than committing to a single long-term outcome, IBUF recalculates its cap and buffer every three months, allowing adaptation to evolving market conditions. Combined with the exchange-traded format, this creates a distinct option among international equity products.
Several risks warrant attention. The upside cap restricts maximum returns in any outcome period, even if underlying markets rise sharply. The 10% buffer covers only the initial 10% of losses; further declines are passed through on a one-to-one basis, and achievement of the buffer is not guaranteed.
Buffer and cap benefits generally require holding through the full outcome period. Buying or selling mid-period can lead to different results. Other considerations include the complexity of FLEX Options, counterparty risk, tracking differences versus EFA, interest-rate and currency sensitivity, and the non-diversified structure. The 0.85% expense ratio is another factor to weigh against the defined-outcome features.
The Innovator International Developed 10 Buffer ETF - Quarterly (IBUF) carves out a specific place in the ETF landscape. By combining international developed-market exposure with a quarterly 10% buffer and capped upside, it delivers a defined risk-and-return profile distinct from conventional index products. For those who prioritize downside protection and accept limited upside in exchange, IBUF offers a structured, transparent route to markets outside the United States.
In my own analysis, I frequently rely on Tickeron's AI Screener when evaluating defined-outcome ETFs like IBUF. The platform helps surface ideas by screening on technical indicators, fundamentals, volatility, trends, AI signals, industries, and price patterns, making it easier to align opportunities with specific strategies.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.
The RSI Oscillator for IBUF moved into overbought territory on November 20, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +0.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where IBUF advanced for three days, in 101 of 161 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
IBUF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 142 of 236 cases where IBUF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 60%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IBUF as a result. In 13 of 33 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 39%.
The Moving Average Convergence Divergence Histogram (MACD) for IBUF turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 24 similar instances when the indicator turned negative. In 4 of the 24 cases the stock turned lower in the days that followed. This puts the odds of success at 17%.
IBUF moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBUF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 35%.